EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A scalable tumor-vasculature-on-chip for CAR T cell trafficking and efficacy studies

Luuk de Haan iD, Aleksandra Olczyk, Thomas Olivier, Joris Wesselius, Johnny Suijker, Claudia Al-Mardini, Todd P Burton, Lenie van den Broek, Karla Queiroz iD

Biofabrication · 19.11.2026

DOI: 10.1088/1758-5090/aec480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biofabrication, online erschienen am 19.11.2026. Verfasst von Luuk de Haan und 8 weiteren Autor:innen. Beteiligte Einrichtung: MIMETAS BV, De Limes 7, Oegstgeest, 2342DH, Netherlands. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oncode Accelerator.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most cellular therapies, like CAR T cells, remain ineffective in solid tumors. This is primarily due to a complex tumor microenvironment (TME), which creates biochemically hostile and often immunosuppressive conditions that limit efficacy of immunotherapies. Besides, cellular therapy efficacy is still often established in traditional 2D cultures that fail to simulate relevant aspects of solid tumor biology. Recent advances in three-dimensional (3D) and organ-on-chip culture systems have provided more physiologically relevant models for immunotherapy testing. These microphysiological systems (MPS) not only offer a 3D environment that alters tumor cell sensitivity to therapy but also enable inclusion of TME components and assessment of processes such as extravasation and infiltration, key steps in CAR T cell activity in vivo. This study focuses on applying an advanced culture technique and further building on the use of a scalable on-chip platform, the OrganoPlate, to grow EpCAM-positive and EpCAM-negative tumor cells in coculture with an endothelial vessel to study EpCAM-targeting CAR T cell migration and killing kinetics. The CAR T cells specifically targeted and killed EpCAM-positive HT-29 tumor cells while EpCAM-negative A375 tumor cells were not affected. In addition, target cell killing was dependent on the ratio between CAR T and tumor cells (E:T ratio) and was enhanced by addition of IL-2. Inflammatory cytokines like INF-γ, TNFα and IL-6 increased overtime in cultures containing CAR T cells. Morphometric analyses of the endothelial compartment showed E:T ratio dependent disruption of endothelial vessels. Additionally, this system was able to distinguish EpCAM ScFv-CD28-CD3z and EpCAM ScFv-TM-4-1BB-CD3z CAR T cells killing abilities and was used for studying the effect of immune checkpoint inhibitors and Temozolomide, a DNA targeting drug, on CAR T cell performance. Altogether, this work adds to the available advanced culture techniques for immunotherapy developers by describing a model that is modular, scalable, and suitable for phenotypic and functional characterization of CAR T cells.

Schlagwörter

Stichwörter der Autor:innen

3D cell cultureCAR T cellsHigh-throughput applicationImmuno-oncologyImmunotherapyMPSmicrofluidics

Autor:innen und Institutionen

  • MIMETAS BV, De Limes 7, Oegstgeest, 2342DH, Netherlands.

ORCID-Profile: Luuk de Haan, Karla Queiroz

Förderung

  • Oncode Accelerator

Zitieren

APA

de Haan, L., Olczyk, A., Olivier, T., Wesselius, J., Suijker, J., Al-Mardini, C., Burton, T. P., Broek, L. V. D., & Queiroz, K. (2026). A scalable tumor-vasculature-on-chip for CAR T cell trafficking and efficacy studies. Biofabrication. https://doi.org/10.1088/1758-5090/aec480

Vancouver

de Haan L, Olczyk A, Olivier T, Wesselius J, Suijker J, Al-Mardini C, et al. A scalable tumor-vasculature-on-chip for CAR T cell trafficking and efficacy studies. Biofabrication. 2026. doi:10.1088/1758-5090/aec480

BibTeX
@article{deHaan2026,
  author = {de Haan, Luuk and Olczyk, Aleksandra and Olivier, Thomas and Wesselius, Joris and Suijker, Johnny and Al-Mardini, Claudia and Burton, Todd P and Broek, Lenie van den and Queiroz, Karla},
  title = {A scalable tumor-vasculature-on-chip for CAR T cell trafficking and efficacy studies},
  journal = {Biofabrication},
  year = {2026},
  doi = {10.1088/1758-5090/aec480}
}
Kostenlos starten →